THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL

DOI10.1081/BIP-100101194MaRDI QIDQ4512641zbMATH OpenWikidataFDO

Authors G. Y. H. Chi, Qing Liu

Publication date 1999

Published in Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites work

• A Comparison of Two Methods for Adaptive Interim Analyses in Clinical Trials
• A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance
• Confidence Bands for Cumulative Incidence Curves Under the Additive Risk Model
• Designed Extension of Studies Based on Conditional Power
• Evaluation of Experiments with Adaptive Interim Analyses
• Optimization of Multistage Testing Times and Critical Values in Clinical Trials
• Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance

Cited in

(3)

• Basic concepts of group sequential and adaptive group sequential test procedures
• Optimal Conditional Error Functions for the Control of Conditional Power
• Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin

This page was built for publication: THE ATTRACTIVENESS OF THE CONCEPT OF A PROSPECTIVELY DESIGNED TWO-STAGE CLINICAL TRIAL

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4512641)